Skip to content

Shanghai Eye Study for Adults

Shanghai Eye Study for Adults

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03455478
Acronym
SESA
Enrollment
1000000
Registered
2018-03-06
Start date
2016-01-01
Completion date
2026-11-30
Last updated
2022-05-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blindness,Visual Impairment, Refractive Error, Cataract, High Myopia, Aging

Brief summary

Blindness and visual impairment severely impact the visual health and life quality of people, particularly the 2.566 million senior citizens aged at 65 and above in Shanghai. The main reason is uncorrected refractive error, of which, 62.1% can be solved through refractive correction. For this reason, the uncorrected refractive errors of 154,000 senior citizens in Shanghai can be taken as a priority among the public health issues to prevent blindness. Now, with the aim to reduce the prevalence rate of blindness and visual impairment, it is planned to establish a public health service mechanism in terms of refractive error screening and correction for the elderly by relying on Shanghai's three-level (city-district-community) eye diseases prevention network, using proper refractive correction technology, and moving related services forward to communities in order to screen, identity, and correct blindness and visual impairment caused by refractive errors as early as possible.

Interventions

DEVICEspectacles

dispending spectacles for uncorrected refractive error

Sponsors

Brien Holden Vision
CollaboratorINDUSTRY
Shanghai Eye Disease Prevention and Treatment Center
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
SCREENING
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
Yes

Inclusion criteria

* shanghai residents aged ≥18 years old

Exclusion criteria

* cognitive and/or mobility disorders; non-shanghai residents; younger than 18 years old.

Design outcomes

Primary

MeasureTime frameDescription
best-corrected visual acuity (BCVA)5 yearsthe prevalence of blindness and visual impairment
cataract surgery rate5 yearscataract surgery rate of Shanghai older people
cataract surgery coverage rate5 yearscataract surgery coverage rate of Shanghai cataract patients
visual impairment caused by high myopia5 yearsobserving the rate of visual impairment caused by high myopia

Countries

China

Contacts

Primary ContactXun Xu, MD
drxuxun@tom.com8613386259538

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026